$NVTA look, stocks go up and down, even the best of them. What makes me feel good this time around is the group of partners they needed to align with to back this deal. With the shares they’ve sold, the money they have attracted, and the credit line they’ve established, many good firms and people have joined in and signed off on this deal. My belief is they will be leading a genomics industry just ramping up into playing a major role in the healthcare industry. if you are a long-term investor, say three years to five years for starters, I think there is no doubt you see the stock in triple digits. When taking that ride, there is no doubt there will be dips of 10% to 20% here and there, but you will have done very well just holding and watching this play out. glta
  • 11